Gain Clarity from European Regulatory Expectations to Advance Innovative Biomarker & Diagnostic-Driven Therapies Towards the Clinic with Optimized Market Access & Patient Adoption
The highly anticipated 12th Clinical Biomarkers & CDx Summit Europe will return in 2022 as Europe’s only end-to-end clinical biomarker and companion diagnostics summit bringing you the latest intelligence to reinvigorate your precision medicine strategy.
As the field witnesses greater numbers of exciting Drug-Dx approvals being driven by major advancements in biomarker development, the CB & CDx event sets the stage for key learnings with exclusive data to you optimize your drug development programs in precision medicine from start to finish.
Against the backdrop of complex regulatory changes creating industry-wide uncertainty, now more than ever before it’s important you unite with 300+ Precision Medicine, Biomarker & Diagnostic experts. This timely forum, which combines a mix of workshops, formal presentations, panels, live tech demos, networking & collaborative discussion, is your only summit to build the foundation for successful and regulatory adherent collaborations for 2022 & beyond!
Delving deep into the most ground-breaking work enabling patient population identification, and pairing this with revelations from cutting-edge commercial strategies, this is an industry poised to gain actionable insights maximising access to game-changing precision medicines and testing technology.
Agenda launching soon – register your interest to attend now!
Content & Discussions Not to Miss: Agenda at a Glance
Designed for the entire value chain of precision drug development
Clinical Biomarker Development Stream
Designed for preclinical, translational & clinical leaders
|Drug-Dx Commercialization Stream
Designed for regulatory, precision medicine, CDx & commercial leaders
Expert Speakers Who Joined in 2021 Included:
Head, Global Scientific Affairs, Innovation & Companion Diagnostics
Head, Executive Director, Global Regulatory Affairs, Translational Medicine & Devices
Precision Medicine Expert, Cardiovascular, Renal and Metabolism
Senior Medical Oncologist, Head of the Department of Drug Development and Innovation (D3i)
Vice President, Translational Medicine
Global Director Medical Affairs, Oncology, Thoracic & Pan Tumor Biomarkers & Diagnostics, Oncology Global Medical Affairs
Merck & Co.
Hear What Our Attendees Say
“Fantastic organisation along with facilitation of effective networking. Conference content well thought through covering major discussion points within the field of Companion Diagnostics & Clinical Biomarkers.”
“It was great as ever, both from content as well as networking opportunity. The Hanson Wade Team has again done a great job.”
“The Hansonwade team are really on the ball when it comes to customer service, industry insights and understanding what makes an event work. Great location this year and look forward to the next event!”